Drug and Therapeutics Bulletin 1997;35:70-72; doi:10.1136/dtb.1997.35970
Copyright © 1997 by the BMJ Publishing Group Ltd.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

{blacktriangledown}Acamprosate for alcohol dependence?

Relevant BNF section: 4.10

People dependent on alcohol who undergo detoxification commonly relapse into further drinking, despite rehabilitation measures. Acamprosate (Campral EC-Lipha) was launched in the UK in 1996 to be used, with counselling, in maintaining abstinence after alcohol withdrawal in patients with known dependence. Here we review its effects.




This article has been cited by other articles:


Home page
 BMJHome page
D. M Keeling, C C H Cook, A D Thomson, A. Herran, J. L. Vazquez-Barquero, P. Haddad, C. Daly, M. Ashworth, and C. Gerada
Treating alcohol dependence
BMJ, November 29, 1997; 315(7120): 1465 - 1465.
[Full Text]


About DTB - Privacy policy - Terms and conditions relating to subscriptions purchased online - Web site terms and conditions - Feedback

© 1997 BMJ Publishing Group Ltd.